Madam Speaker, we have learned over this ordeal how important it is to have self-sufficiency as it pertains to pharmaceutical production, in both research and development.
When Pierre Trudeau was prime minister, he changed the Patent Act and the pharmaceutical companies left. It was our first brain drain within the medical community. Now the Prime Minister has made changes to price controls. He is increasing the price controls and increasing the disincentive for pharmaceutical companies to come and, if they are here, to stay here.
What other changes are going to be made? The government is throwing money at the problem, but what changes are going to be made to attract and retain research and development pharmaceutical companies in Canada?